The strategic response of the Revolutionary Government and its scientists to the COVID-19 pandemic took center stage in the consultative work of the Cuban Academy of Sciences (ACC) in 2021.

In accordance with the development of the application of the Cuban anti-COVID-19 Abdala vaccine booster in the province of Matanzas, more than 300, 000 doses have been administered so far in the territory, Lissy Vega Rodriguez, in charge of the immunization, exclusively told Cuban News Agency.

Cuba studied a total of 35,815 samples for surveillance during the day, 2,685 of which were positive. The country accumulates 12, 002,043 samples taken and 982,614 positive.

With the delivery to the province of Holguin of 500, 000 doses of the Cuban vaccine Abdala, the eastern territory extends the booster immunization to populations and groups at risk, as part of the priorities of the public health sector for the control of the COVID-19.

The booster vaccination, with a single dose of the nationally produced drug Soberana 01, is being extended from today to all the municipalities of Cienfuegos, due to the increase in the number of infections by COVID-19 and the presence of the omicron variant of the SARS-CoV-2 virus in the province.

Citizen indiscipline in the fulfillment of hygienic sanitary measures and the presence of the omicron variant of the SARS-CoV-2 virus have had a significant impact on the increase of COVID-19 cases in the province of Matanzas during the last few days.

The Cuban public health ministry (MINSAP) reported today that 86.9 % of the country's population has completed the vaccination against COVID-19, with the national drugs Soberana 02, Soberana Plus and Abdala.

The Molecular Biology Laboratory (LBM) of the province of Ciego de Avila supports the development of tourist operations in the Jardines del Rey destination by processing up to 500 samples per day for PCR to travelers.

Cuba studied a total of 41,597 samples for surveillance during the day, resulting in 2,519 positive results. The country accumulates 11, 966,228 samples taken and 979,929 were positive.

The events marking Cuban Science Day will continue until April, a sign of the importance of this date established in 1990 at the instance of Commander-in-Chief Fidel Castro.

The 86.7 % of the Cuban population has already completed the anti-COVID-19 vaccination program, with the national immunogens Soberana 02, Soberana Plus and Abdala.

Cuba studied a total of 37,980 samples for surveillance during the day, resulting positive 1,946. The country accumulates 11, 836,693 samples taken and 972,513 were positive.

Cuba continues advancing in the administration of national anti-COVID-19 vaccines, and by the end of January 4, 30, 925,470 doses of Soberana 02, Soberana Plus and Abdala had been administered in the country.

Cuba keeps advancing the mass administration of locally developed COVID-19 vaccines with 30 million 925 thousand 470 doses up to January 4th.